Trial Profile
Clinical Trials Insight: 700033592
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 15 May 2008
Price :
$35
*
At a glance
- Drugs Levosalbutamol/ipratropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors Sunovion Pharmaceuticals
- 15 May 2008 New trial record.